2020
DOI: 10.3906/kim-2007-37
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and pharmacological effects of novel benzenesulfonamides carrying benzamide moiety as carbonic anhydrase and acetylcholinesterase inhibitors

Abstract: N -(1-(4-Methoxyphenyl)-3-oxo-3-((4-( N -(substituted)sulfamoyl)phenyl)amino)prop-1-en-1-yl)benzamides 3a – g were designed since sulfonamide and benzamide pharmacophores draw great attention in novel drug design due to their wide range of bioactivities including acetylcholinesterase (AChE) and human carbonic anhydrase I and II (hCA I and hCA II) inhibitory potencies. Structure elucidation of the compounds was carried out by 1H NMR, 13C NMR, and HRMS spe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 39 publications
(60 reference statements)
0
4
0
Order By: Relevance
“…Acetylcholinesterase [55], butyrylcholine esterase [55], tyrosinase [56], α-amylase [58], α-glucosidase inhibition [58] activity results were made according to spectrophotometric methods. IC 50 values were calculated and given in Table 4.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Acetylcholinesterase [55], butyrylcholine esterase [55], tyrosinase [56], α-amylase [58], α-glucosidase inhibition [58] activity results were made according to spectrophotometric methods. IC 50 values were calculated and given in Table 4.…”
Section: Resultsmentioning
confidence: 99%
“…Sample and blank absorbances were read after 10 min of incubation at 25 °C at 405 nm. Acetylcholinesterase inhibitory activity was given equivalent to galantamine [55], and the results were given in Table 4.…”
Section: Enzyme Inhibitions Acetylcholinesterase (Ache) Inhibitionmentioning
confidence: 99%
“…The experimental properties for 17–19, 25–30 and 33–35 matched with those reported in literature. [ 26 , 27 , 28 , 29 , 30 , 31 , 32 ]…”
Section: Methodsmentioning
confidence: 99%
“…Because of this role, α-glucosidase has been proposed as a potential therapeutic target for the treatment of type-2 diabetes in people. [14,15] In the literature, it is observed that many newly synthesized organic compounds including isatin mannich bases, [16] tetrahydropyrimidine-5-carboxylates, [17] diaryl ethers, [18] 4,5-disubstituted-2-thioxo-1,2,3,4-tetrahydropyrimidines, [19] bromophenols, [20] cyclic thioureas, [21] sulfamides derived from βbenzylphenethylamines, [22] new amides and thiazolidineones synthesized on an acetophenone base, [23] aminomethyl and alkoxymethyl derivatives, [24] 2-hydroxyethyl substituted NHC precursors, [25] phloroglucinol derivatives, [26] novel N,N'-biscyanomethylamine and alkoxymethylamine derivatives, [27] Meta-cyanobenzyl substituted benzimidazoles, [28] novel amides of 1,1-bis-(carboxymethylthio)-1-arylethanes, [29] novel trischalcones, [30] imidazole derivatives, bis-sulfone derivatives, [31] novel benzo[b]xanthene derivatives, [32] nitrogen, phosphorus, selenium and sulfur-containing heterocyclic compounds, [33] Schiff bases containing phenol ring, [34] and piperazine derivatives [35] effectively inhibit AChE and BChE enzymes. All of these newly synthesized molecules, which inhibit both cholinergic enzymes, contain many functional groups that are important for biological activity.…”
Section: Introductionmentioning
confidence: 99%